Inclusion Criteria:
  1. Subject must have a diagnosis of LOPD based on documentation of one of the following:
       1. deficiency of GAA enzyme
       2. GAA genotyping
  2. Subject must provide signed informed consent prior to any study-related procedures being performed.
Exclusion Criteria:
  1. Subject is eligible for enrollment in an ongoing clinical trial using ATB200/AT2221.
  2. Subject, if female, is pregnant or breastfeeding at screening.
  3. Subject, whether male or female, is planning to conceive a child during the study.